Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Bergmann is active.

Publication


Featured researches published by M. Bergmann.


The New England Journal of Medicine | 2008

General and Abdominal Adiposity and Risk of Death in Europe

Tobias Pischon; Heiner Boeing; Kurt Hoffmann; M. Bergmann; Matthias B. Schulze; Kim Overvad; Y. T. van der Schouw; Elizabeth A Spencer; Karel G.M. Moons; Anne Tjønneland; Jytte Halkjær; Majken K. Jensen; Jakob Stegger; F. Clavel-Chapelon; M. C. Boutron-Ruault; Véronique Chajès; Jakob Linseisen; R. Kaaks; Antonia Trichopoulou; Dimitrios Trichopoulos; Christina Bamia; S. Sieri; Domenico Palli; R. Tumino; Paolo Vineis; Salvatore Panico; P.H.M. Peeters; Anne May; H. B. Bueno-de-Mesquita; F.J.B van Duijnhoven

BACKGROUNDnPrevious studies have relied predominantly on the body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) to assess the association of adiposity with the risk of death, but few have examined whether the distribution of body fat contributes to the prediction of death.nnnMETHODSnWe examined the association of BMI, waist circumference, and waist-to-hip ratio with the risk of death among 359,387 participants from nine countries in the European Prospective Investigation into Cancer and Nutrition (EPIC). We used a Cox regression analysis, with age as the time variable, and stratified the models according to study center and age at recruitment, with further adjustment for educational level, smoking status, alcohol consumption, physical activity, and height.nnnRESULTSnDuring a mean follow-up of 9.7 years, 14,723 participants died. The lowest risks of death related to BMI were observed at a BMI of 25.3 for men and 24.3 for women. After adjustment for BMI, waist circumference and waist-to-hip ratio were strongly associated with the risk of death. Relative risks among men and women in the highest quintile of waist circumference were 2.05 (95% confidence interval [CI], 1.80 to 2.33) and 1.78 (95% CI, 1.56 to 2.04), respectively, and in the highest quintile of waist-to-hip ratio, the relative risks were 1.68 (95% CI, 1.53 to 1.84) and 1.51 (95% CI, 1.37 to 1.66), respectively. BMI remained significantly associated with the risk of death in models that included waist circumference or waist-to-hip ratio (P<0.001).nnnCONCLUSIONSnThese data suggest that both general adiposity and abdominal adiposity are associated with the risk of death and support the use of waist circumference or waist-to-hip ratio in addition to BMI in assessing the risk of death.


BMJ | 2010

Association between Pre-Diagnostic Circulating Vitamin D Concentration and Risk of Colorectal Cancer in European Populations: a Nested Case-Control Study

Mazda Jenab; H. Bas Bueno-de-Mesquita; Pietro Ferrari; Fränzel J.B. Van Duijnhoven; Teresa Norat; Tobias Pischon; Eugene Jansen; Nadia Slimani; Graham Byrnes; Sabina Rinaldi; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; M. Bergmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Franco Berrino; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Martine M. Ros; Carla H. van Gils

Objective To examine the association between pre-diagnostic circulating vitamin D concentration, dietary intake of vitamin D and calcium, and the risk of colorectal cancer in European populations. Design Nested case-control study. Setting The study was conducted within the EPIC study, a cohort of more than 520u2009000 participants from 10 western European countries. Participants 1248 cases of incident colorectal cancer, which developed after enrolment into the cohort, were matched to 1248 controls Main outcome measures Circulating vitamin D concentration (25-hydroxy-vitamin-D, 25-(OH)D) was measured by enzyme immunoassay. Dietary and lifestyle data were obtained from questionnaires. Incidence rate ratios and 95% confidence intervals for the risk of colorectal cancer by 25-(OH)D concentration and levels of dietary calcium and vitamin D intake were estimated from multivariate conditional logistic regression models, with adjustment for potential dietary and other confounders. Results 25-(OH)D concentration showed a strong inverse linear dose-response association with risk of colorectal cancer (P for trend <0.001). Compared with a pre-defined mid-level concentration of 25-(OH)D (50.0-75.0 nmol/l), lower levels were associated with higher colorectal cancer risk (<25.0 nmol/l: incidence rate ratio 1.32 (95% confidence interval 0.87 to 2.01); 25.0-49.9 nmol/l: 1.28 (1.05 to 1.56), and higher concentrations associated with lower risk (75.0-99.9 nmol/l: 0.88 (0.68 to 1.13); ≥100.0 nmol/l: 0.77 (0.56 to 1.06)). In analyses by quintile of 25-(OH)D concentration, patients in the highest quintile had a 40% lower risk of colorectal cancer than did those in the lowest quintile (P<0.001). Subgroup analyses showed a strong association for colon but not rectal cancer (P for heterogeneity=0.048). Greater dietary intake of calcium was associated with a lower colorectal cancer risk. Dietary vitamin D was not associated with disease risk. Findings did not vary by sex and were not altered by corrections for season or month of blood donation. Conclusions The results of this large observational study indicate a strong inverse association between levels of pre-diagnostic 25-(OH)D concentration and risk of colorectal cancer in western European populations. Further randomised trials are needed to assess whether increases in circulating 25-(OH)D concentration can effectively decrease the risk of colorectal cancer.


Digestion | 2008

Diet in the aetiology of ulcerative colitis: A European prospective cohort study

Andrew Hart; Robert Luben; Anja Olsen; Anne Tjønneland; Jakob Linseisen; Gabriele Nagel; Göran Berglund; Stefan Lindgren; Olof Grip; Timothy J. Key; Paul N. Appleby; M. Bergmann; Heiner Boeing; Göran Hallmans; Richard Palmqvist; Hubert Sjodin; Gun Hägglund; Kim Overvad; Domenico Palli; Giovanna Masala; Elio Riboli; Hugh J. Kennedy; Ailsa Welch; Kay-Tee Khaw; Nicholas E. Day; Sheila Bingham

Background/Aims: The causes of ulcerative colitis are unknown, although it is plausible that dietary factors are involved. Case-control studies of diet and ulcerative colitis are subject to recall biases. The aim of this study was to examine the prospective relationship between the intake of nutrients and the development of ulcerative colitis in a cohort study. Methods: The study population was 260,686 men and women aged 20–80 years, participating in a large European prospective cohort study (EPIC). Participants were residents in the UK, Sweden, Denmark, Germany or Italy. Information on diet was supplied and the subjects were followed up for the development of ulcerative colitis. Each incident case was matched with four controls and dietary variables were divided into quartiles. Results: A total of 139 subjects with incident ulcerative colitis were identified. No dietary associations were detected, apart from a marginally significant positive association with an increasing percentage intake of energy from total polyunsaturated fatty acids (trend across quartiles OR = 1.19 (95% CI = 0.99–1.43) p = 0.07). Conclusions: No associations between ulcerative colitis and diet were detected, apart from a possible increased risk with a higher total polyunsaturated fatty acid intake. A biological mechanism exists in that polyunsaturated fatty acids are metabolised to pro-inflammatory mediators.


American Journal of Epidemiology | 2010

Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition

Naomi E. Allen; Konstantinos K. Tsilidis; Timothy J. Key; Laure Dossus; Rudolf Kaaks; Eiliv Lund; Kjersti Bakken; Oxana Gavrilyuk; Kim Overvad; Anne Tjønneland; Anja Olsen; Agnès Fournier; Alban Fabre; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet; C. Sacerdote; Vittorio Krogh; Benedetta Bendinelli; Rosario Tumino; Salvatore Panico; M. Bergmann; Madlen Schuetze; Fränzel J.B. Van Duijnhoven; H. Bas Bueno-de-Mesquita; N. Charlotte Onland-Moret; Carla H. van Gils; Pilar Amiano; Aurelio Barricarte; Maria-Dolores Chirlaque; Maria-Esther Molina-Montes

Estrogen-only menopausal hormone therapy (HT) increases the risk of endometrial cancer, but less is known about the association with other types of HT. Using Cox proportional hazards regression, the authors examined the association of various types of HT with the risk of endometrial cancer among 115,474 postmenopausal women recruited into the European Prospective Investigation into Cancer and Nutrition between 1992 and 2000. After a mean follow-up period of 9 years, 601 incident cases of endometrial cancer were identified. In comparison with never users of HT, risk of endometrial cancer was increased among current users of estrogen-only HT (hazard ratio (HR) = 2.52, 95% confidence interval (CI): 1.77, 3.57), tibolone (HR = 2.96, 95% CI: 1.67, 5.26), and, to a lesser extent, estrogen-plus-progestin HT (HR = 1.41, 95% CI: 1.08, 1.83), although risks differed according to regimen and type of progestin constituent. The association of HT use with risk was stronger among women who were older, leaner, or had ever smoked cigarettes. The finding of a strong increased risk of endometrial cancer with estrogen-only HT and a weaker association with combined HT supports the hypothesis that progestins have an attenuating effect on endometrial cancer risk. The increased risk associated with tibolone use requires further investigation.


International Journal of Obesity | 2009

A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study

Hervé Besson; Ulf Ekelund; J. Luan; Anne May; Stephen J. Sharp; Noémie Travier; Antonio Agudo; Nadia Slimani; S. Rinaldi; Mazda Jenab; Teresa Norat; T Mouw; Sabine Rohrmann; R. Kaaks; M. Bergmann; Heiner Boeing; F. Clavel-Chapelon; M. C. Boutron-Ruault; Kim Overvad; Elizabeth Lykholt Andreasen; N Føns Johnsen; Jytte Halkjær; Clementina González; Laudina Rodríguez; M. J. Sánchez; Larraitz Arriola; Aurelio Barricarte; C. Navarro; Timothy J. Key; Elizabeth A. Spencer

Objectives:Cross-sectional data suggest a strong association between low levels of physical activity and obesity. The EPIC-PANACEA (European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project was designed to investigate the associations between physical activity and body mass index (BMI) and waist circumference based on individual data collected across nine European countries.Methods:In the European Prospective Investigation into Cancer and Nutrition (EPIC), 519u2009931 volunteers were recruited between 1992 and 2000, of whom 405u2009819 had data on main variables of interest. Height, body weight and waist circumference were measured using standardized procedures. Physical activity was assessed using a validated four-category index reflecting a self-reported usual activity during work and leisure time. The associations between physical activity and BMI and waist circumference were estimated using multilevel mixed effects linear regression models, adjusted for age, total energy intake, smoking status, alcohol consumption and educational level.Results:A total of 125u2009629 men and 280u2009190 women with a mean age of 52.9 (s.d. 9.7) and 51.5 (s.d. 10.0) years, respectively were included. The mean BMI was 26.6u2009kg/m2 (s.d. 3.6) in men and 25.0u2009kg/m2 (s.d. 4.5) in women. Fifty percent of men and 30% of women were categorized as being active or moderately active. A one-category difference in the physical activity index was inversely associated with a difference of 0.18u2009kg/m2 in the mean BMI (95% confidence interval, CI, 0.11, 0.24) and 1.04-cm (95% CI 0.82, 1.26) difference in waist circumference in men. The equivalent figures for women were 0.31u2009kg/m2 (95% CI 0.23, 0.38) and 0.90u2009cm (95% CI 0.71, 1.08), respectively.Conclusions:Physical activity is inversely associated with both BMI and waist circumference across nine European countries. Although we cannot interpret the association causally, our results were observed in a large and diverse cohort independently from many potential confounders.


British Journal of Cancer | 2010

Oral contraceptives, reproductive history and risk of colorectal cancer in the European prospective investigation into cancer and nutrition

Konstantinos K. Tsilidis; Naomi E. Allen; Timothy J. Key; Kjersti Bakken; Eiliv Lund; Franco Berrino; Agnès Fournier; A. Olsen; Anne Tjønneland; Kim Overvad; M. C. Boutron-Ruault; F. Clavel-Chapelon; Graham Byrnes; Véronique Chajès; S. Rinaldi; Jenny Chang-Claude; R. Kaaks; M. Bergmann; Heiner Boeing; Yvoni Koumantaki; G. Stasinopoulou; Antonia Trichopoulou; Domenico Palli; Giovanna Tagliabue; Salvatore Panico; R. Tumino; Paolo Vineis; H. B. Bueno-De-Mesquita; F.J.B van Duijnhoven; C. H. van Gils

Background:Oral contraceptive use and reproductive factors may initiate long-term changes to the hormonal milieu and thereby, possibly influence colorectal cancer risk.Methods:We examined the association of hormonal and reproductive factors with risk of colorectal cancer among 337u2009802 women in the European Prospective Investigation into Cancer and Nutrition, of whom 1878 developed colorectal cancer.Results:After stratification for center and age, and adjustment for body mass index, smoking, diabetes mellitus, physical activity and alcohol consumption, ever use of oral contraceptives was marginally inversely associated with colorectal cancer risk (hazard ratio (HR), 0.92; 95% confidence interval (CI), 0.83–1.02), although this association was stronger among post-menopausal women (HR, 0.84; 95% CI: 0.74–0.95). Duration of oral contraceptive use and reproductive factors, including age at menarche, age at menopause, type of menopause, ever having an abortion, parity, age at first full-term pregnancy and breastfeeding, were not associated with colorectal cancer risk.Conclusion:Our findings provide limited support for a potential inverse association between oral contraceptives and colorectal cancer risk.


Alimentary Pharmacology & Therapeutics | 2011

Aspirin in the aetiology of Crohn’s disease and ulcerative colitis: a European prospective cohort study

Simon S. M. Chan; Robert Luben; M. Bergmann; Heiner Boeing; A. Olsen; Anne Tjønneland; Kim Overvad; R. Kaaks; Hugh J. Kennedy; Kay-Tee Khaw; E. Riboli; Andrew Hart

Aliment Pharmacol Ther 2011; 34: 649–655


European Journal of Clinical Nutrition | 2009

Alcohol consumption patterns, diet and body weight in 10 European countries

S. Sieri; V. Krogh; Calogero Saieva; Diederick E. Grobbee; M. Bergmann; Sabine Rohrmann; Anne Tjønneland; Pietro Ferrari; Y. Chloptsios; Vardis Dilis; Mazda Jenab; J. Linseisen; Peter Wallström; Ingegerd Johansson; M. D. Chirlaque; M. J. Sánchez; M. Niravong; F. Clavel-Chapelon; Ailsa Welch; Naomi E. Allen; H. B. Bueno-de-Mesquita; Y. T. van der Schouw; C. Sacerdote; Salvatore Panico; Christine L. Parr; Tonje Braaten; A. Olsen; Majken K. Jensen; S. Bingham; E. Riboli

Background/objectives:Europe has the highest level of alcohol consumption in the world. As drinking patterns are important determinants of the beneficial and harmful effects of alcohol consumption, we investigated alcohol consumption in relation to nutrient intake, place of consumption, education and body weight in a sample of adults from 10 European countries.Methods:A 24-h dietary recall interview was conducted on 13u2009025 men and 23u2009009 women, aged 35–74 years, from 27 centres participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Means and standard errors of alcohol consumption, adjusted for age, were calculated, stratified by gender and centre.Results:In many centres, higher level drinkers (males consuming >24u2009g of ethanol/day, equivalent to >2 standard drinks and females consuming >12u2009g of ethanol/day equivalent to >1 standard drink) obtained more energy from fat and protein and less from sugar than did abstainers. The proportion of energy from starch tended to be higher for male and lower for female higher level drinkers than for abstainers. Female higher level drinkers had a lower body mass index than did abstainers, whereas male higher level drinkers generally weighed more. Male higher level drinkers were less educated than abstainers in Mediterranean countries, but were more educated elsewhere. Female higher level drinkers were usually more educated than were abstainers. Outside the home, consumption (both genders) tended to be at friends homes, particularly among men in Northern and Central Europe, and in bars in Spain.Conclusions:This study reveals clear geographical differences in drinking habits across Europe, and shows that the characteristics of different alcohol consumption categories also vary.


European Journal of Clinical Nutrition | 2009

Energy intake and sources of energy intake in the European Prospective Investigation into Cancer and Nutrition.

Marga C. Ocké; Nerea Larrañaga; Sara Grioni; S. W. van den Berg; Pietro Ferrari; Simonetta Salvini; Vassiliki Benetou; J. Linseisen; Elisabet Wirfält; S. Rinaldi; Mazda Jenab; Jytte Halkjær; Marianne Uhre Jakobsen; M. Niravong; F. Clavel-Chapelon; R. Kaaks; M. Bergmann; E. Moutsiou; Antonia Trichopoulou; C. Lauria; C. Sacerdote; H. B. Bueno-de-Mesquita; Petra H. Peeters; Anette Hjartåker; Christine L. Parr; M. J. Tormo; M. J. Sánchez; Jonas Manjer; Veronica Hellstrom; A. Mulligan

Objectives:To describe energy intake and its macronutrient and food sources among 27 regions in 10 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Methods:Between 1995 and 2000, 36u2009034 subjects aged 35–74 years were administered a standardized 24-h dietary recall. Intakes of macronutrients (g/day) and energy (kcal/day) were estimated using standardized national nutrient databases. Mean intakes were weighted by season and day of the week and were adjusted for age, height and weight, after stratification by gender. Extreme low- and high-energy reporters were identified using Goldbergs cutoff points (ratio of energy intake and estimated basal metabolic rate <0.88 or >2.72), and their effects on macronutrient and energy intakes were studied.Results:Low-energy reporting was more prevalent in women than in men. The exclusion of extreme-energy reporters substantially lowered the EPIC-wide range in mean energy intake from 2196–2877 to 2309–2866u2009kcal among men. For women, these ranges were 1659–2070 and 1873–2108u2009kcal. There was no north–south gradient in energy intake or in the prevalence of low-energy reporting. In most centres, cereals and cereal products were the largest contributors to energy intake. The food groups meat, dairy products and fats and oils were also important energy sources. In many centres, the highest mean energy intakes were observed on Saturdays.Conclusions:These data highlight and quantify the variations and similarities in energy intake and sources of energy intake among 10 European countries. The prevalence of low-energy reporting indicates that the study of energy intake is hampered by the problem of underreporting.


International Journal of Cancer | 2011

Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

Konstantinos K. Tsilidis; Naomi E. Allen; Timothy J. Key; M A Sanjoaquin; Kjersti Bakken; Franco Berrino; Agnès Fournier; Eiliv Lund; Kim Overvad; A. Olsen; Anne Tjønneland; Graham Byrnes; Véronique Chajès; S. Rinaldi; Boutron-Ruault M-C.; F. Clavel-Chapelon; Jenny Chang-Claude; R. Kaaks; M. Bergmann; Heiner Boeing; Yvonni Koumantaki; Domenico Palli; Valeria Pala; Salvatore Panico; R. Tumino; Paolo Vineis; H. Bas Bueno-de-Mesquita; van Duijnhoven Fjb.; C. H. van Gils; Peeters Phm.

Menopausal hormone therapy (HT) may influence colorectal cancer risk. A total of 136,275 postmenopausal women from the European Prospective Investigation into Cancer and Nutrition were followed for an average of 9 years, during which time 1,186 colorectal cancers were diagnosed. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazards models stratified by center and age, and adjusted for body mass index, smoking, diabetes, physical activity and alcohol consumption. Compared to never use of HT at study enrolment, current use of estrogen‐only (HR, 1.02; 95% CI, 0.79–1.31) or estrogen plus progestin (HR, 0.94; 95% CI, 0.77–1.14) was not significantly associated with the risk of colorectal cancer, and these associations did not vary by recency, duration, route of administration, regimen or specific constituent of HT. Our results show no significant association of estrogen‐only or estrogen plus progestin therapy with colorectal cancer risk.

Collaboration


Dive into the M. Bergmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Heiner Boeing

Free University of Berlin

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

R. Kaaks

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Antonia Trichopoulou

National and Kapodistrian University of Athens

View shared research outputs
Top Co-Authors

Avatar

R. Tumino

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Salvatore Panico

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Vineis

Imperial College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge